Mitochondrial DNA mutation associations with ERK/MAPK inhibitor sensitivity in cancer

Genes and Diseases · Published 2026-08-01 · DOI 10.1016/j.gendis.2026.102393

Free full text

Authors (6)

Maryssa Shanteau-Jackson, Vedant Thorat, Tracy Kongai, Tatiana Dombrovski, Jenný Brynjarsdóttir, Thomas LaFramboise

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Shanteau-Jackson, M., Thorat, V., Kongai, T., et al. (2026). Mitochondrial DNA mutation associations with ERK/MAPK inhibitor sensitivity in cancer. Genes and Diseases. https://doi.org/10.1016/j.gendis.2026.102393

Related articles

• Charting the landscape of microbiota in bladder cancer: Molecular mechanisms and therapeutic implications · Genes and Diseases · 2026 · Same journal
• Role of post-translational modifications in cancer metabolic reprogramming · Genes and Diseases · 2026 · Same journal
• SASH3 mutations cause monogenic inflammatory bowel diseases by disrupting NF-κB and mTORC1 pathways · Genes and Diseases · 2026 · Same journal
• Xbp1s regulates cardiac fibrosis by transcriptionally activating Stat3 in mice · Genes and Diseases · 2026 · Same journal
• Loss of CCDC3 alleviates MAFLD and metabolic aging of mice through enhanced AGXT-associated hepatocyte glycine metabolism · Genes and Diseases · 2026 · Same journal
• Enhancer/HMGCS1 axis-mediated lipid metabolism remodeling promotes TAM resistance in ER+ breast cancer · Genes and Diseases · 2026 · Same journal
• Integrative genetic and transcriptomic analyses reveal alternative carcinogenetic pathways in basal cell carcinoma · Genes and Diseases · 2026 · Same journal
• SR-BI deficiency inhibits melanogenesis by attenuating the PKA/CREB signaling axis: Implications for vitiligo · Genes and Diseases · 2026 · Same journal
• Immune cell-derived exosomes in autoimmune diseases: From pathogenic mechanisms to innovative therapeutics · Genes and Diseases · 2026 · Same journal
• Activation of the cGAS–STING pathway mediated by IRGM1 contributes to the development of restrictive cardiomyopathy induced by cTnIR193H mutation · Genes and Diseases · 2026 · Same journal